No Data
No Data
SMBC Nikko Securities decrases its stake in Ribomic(4591.JP) to 9.74%
On Aug 28, SMBC Nikko Securities submitted the Change Report to Ministry of Finance. The report shows that SMBC Nikko Securities decreased their holdings in $Ribomic(4591.JP)$, with their joint
Resil, Medrex, etc.
<176A> Lejiro Co., Ltd. and Komyunikeshon Co., Ltd. shareholding ratio: 11.49% → 12.51%. Reporting obligation start date: August 7, 2024 <2158> FRONTEO Corporation and Capsutan Medical Co., Ltd. shareholding ratio: -% → 6.99%. Reporting obligation start date: August 14, 2024 <2158> FRONTEO Corporation Masahiro Morimoto shareholding ratio: 18.16% → 10.25%. Reporting obligation start date: 20
SMBC Nikko Securities decrases its stake in Ribomic(4591.JP) to 10.76%
On Aug 15, SMBC Nikko Securities submitted the Change Report to Ministry of Finance. The report shows that SMBC Nikko Securities decreased their holdings in $Ribomic(4591.JP)$, with their joint
Ribomic Inc. Reports Quarterly Loss, Stable Assets
Ribomic: March 2025 1st quarter financial results text message [Japanese standard] (non-consolidated)
Ribomic: Announcement of revised financial estimates.
No Data